Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 20 studies | 39% ± 20% | |
| peripheral blood | 19 studies | 45% ± 12% | |
| lung | 17 studies | 25% ± 7% | |
| eye | 9 studies | 36% ± 12% | |
| lymph node | 6 studies | 39% ± 21% | |
| liver | 6 studies | 36% ± 12% | |
| bone marrow | 5 studies | 29% ± 13% | |
| intestine | 4 studies | 34% ± 9% | |
| adipose | 4 studies | 22% ± 7% | |
| breast | 3 studies | 23% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 11378.17 | 2641 / 2642 | 100% | 41.59 | 705 / 705 |
| prostate | 100% | 6724.52 | 244 / 245 | 100% | 26.06 | 501 / 502 |
| breast | 100% | 5770.34 | 459 / 459 | 99% | 92.15 | 1109 / 1118 |
| kidney | 100% | 4739.46 | 89 / 89 | 96% | 20.55 | 869 / 901 |
| thymus | 100% | 5072.19 | 651 / 653 | 97% | 26.00 | 585 / 605 |
| lung | 100% | 7103.32 | 577 / 578 | 93% | 19.32 | 1073 / 1155 |
| uterus | 100% | 7367.05 | 170 / 170 | 93% | 21.07 | 425 / 459 |
| ovary | 100% | 5982.66 | 180 / 180 | 90% | 13.84 | 389 / 430 |
| adrenal gland | 100% | 3560.00 | 258 / 258 | 89% | 20.93 | 204 / 230 |
| skin | 98% | 3629.41 | 1768 / 1809 | 87% | 17.37 | 410 / 472 |
| pancreas | 91% | 2550.15 | 299 / 328 | 92% | 18.96 | 163 / 178 |
| bladder | 100% | 4501.95 | 21 / 21 | 78% | 13.65 | 394 / 504 |
| liver | 100% | 6381.59 | 226 / 226 | 72% | 9.91 | 294 / 406 |
| esophagus | 99% | 3954.68 | 1436 / 1445 | 72% | 10.86 | 131 / 183 |
| stomach | 100% | 3548.56 | 358 / 359 | 53% | 7.00 | 153 / 286 |
| intestine | 98% | 5084.49 | 950 / 966 | 40% | 5.48 | 212 / 527 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 62.07 | 29 / 29 |
| spleen | 100% | 13927.10 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 20.66 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.16 | 1 / 1 |
| adipose | 100% | 4055.23 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 19.34 | 79 / 80 |
| blood vessel | 98% | 3190.96 | 1306 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 94% | 9178.39 | 876 / 929 | 0% | 0 | 0 / 0 |
| heart | 92% | 2907.39 | 793 / 861 | 0% | 0 | 0 / 0 |
| muscle | 64% | 1191.71 | 514 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030838 | Biological process | positive regulation of actin filament polymerization |
| GO_0051496 | Biological process | positive regulation of stress fiber assembly |
| GO_0009887 | Biological process | animal organ morphogenesis |
| GO_0008154 | Biological process | actin polymerization or depolymerization |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0007015 | Biological process | actin filament organization |
| GO_0010633 | Biological process | negative regulation of epithelial cell migration |
| GO_1900028 | Biological process | negative regulation of ruffle assembly |
| GO_0007399 | Biological process | nervous system development |
| GO_0051289 | Biological process | protein homotetramerization |
| GO_0016020 | Cellular component | membrane |
| GO_0005925 | Cellular component | focal adhesion |
| GO_0001725 | Cellular component | stress fiber |
| GO_0005829 | Cellular component | cytosol |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030027 | Cellular component | lamellipodium |
| GO_0003779 | Molecular function | actin binding |
| GO_0005522 | Molecular function | profilin binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0017124 | Molecular function | SH3 domain binding |
| Gene name | EVL |
| Protein name | Enah/Vasp-like EVL protein Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like) |
| Synonyms | RNB6 |
| Description | FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. EVL enhances actin nucleation and polymerization. FUNCTION: Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance, lamellipodial and filopodial dynamics, platelet activation and cell migration. . |
| Accessions | ENST00000557153.5 ENST00000392920.8 [Q9UI08-2] G3V535 G3V2K5 ENST00000557384.5 A0A2D1PGY7 ENST00000555048.5 ENST00000554695.5 Q9UI08 ENST00000555706.5 Q499Z9 H0YJN0 ENST00000544450.6 [Q9UI08-3] ENST00000554031.5 ENST00000402714.6 [Q9UI08-1] ENST00000553875.5 G3V314 ENST00000554045.5 G3V5F7 H0YJL6 A0A087WYI2 G3V3G2 |